PRINCETON, N.J., Jan. 31, 2011 /PRNewswire/ -- Laureate Pharma, Inc. has changed its name to Laureate Biopharmaceutical Services, Inc. (Laureate Biopharma) to better describe the company's positioning in the biopharmaceutical industry. The company's logo has been updated to emphasize "Laureate" and to incorporate a laurel wreath, illustrating Laureate Biopharma's reputation for scientific excellence and commitment to delivery. In addition, the company has established a new homepage (www.lbios.com).
Laureate Biopharma has been in continuous operation in its Princeton, New Jersey facility since 1981. Since 1996, Laureate Biopharma has focused exclusively on serving other developers in the biotherapeutics market.
"We are building on Laureate Biopharma's rich history and adding technologies, capacity and staff, while extending our reputation for quality and delivery," said Michael A. Griffith, Chief Executive Officer. "This name change, although subtle, speaks to our wealth of experience in protein production and a deep scientific bench, which is unique to the industry."
This name change follows the company's announcement of $20 million in secured capital. All strategically planned improvements are continuing as previously announced. These include:
- Adoption of new quality systems technologies
- Upgrade of aseptic fill capabilities
- Upgrade and expansion of protein production facilities and services
- Expansion of mammalian cell line creation services, and
- Launch of a contract analytical testing business
For more information related to Laureate Biopharma's capabilities and ongoing improvements please visit them at their new website, www.lbios.com.
About Laureate Biopharmaceutical